{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:43:47Z","timestamp":1793277827512,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2008-05669"],"award-info":[{"award-number":["2008-05669"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.autrev.2008.12.002","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T04:42:13Z","timestamp":1230266533000},"page":"379-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":324,"title":["CXCL10 and autoimmune diseases"],"prefix":"10.1016","volume":"8","author":[{"given":"Eun Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zang-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2008.12.002_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","article-title":"Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)","volume":"166","author":"Luster","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2008.12.002_bib2","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2008.12.002_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.177.6.1809","article-title":"Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells","volume":"177","author":"Taub","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2008.12.002_bib4","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.165.3.1548","article-title":"CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma","volume":"165","author":"Jinquan","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2008.12.002_bib5","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar616","article-title":"A novel mechanism for the regulation of IFN-\u03b3-inducible protein-10 expression in rheumatoid arthritis","volume":"5","author":"Hanaoka","year":"2003","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.autrev.2008.12.002_bib6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1006\/cyto.2000.0757","article-title":"Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus","volume":"12","author":"Narumi","year":"2000","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.autrev.2008.12.002_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdermsci.2004.03.001","article-title":"Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis","volume":"35","author":"Fujii","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2008.12.002_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"S\u00f8rensen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2008.12.002_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/er.2006-0044","article-title":"Role of chemokines in endocrine autoimmune diseases","volume":"28","author":"Rotondi","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2008.12.002_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/rheumatology\/keg447","article-title":"T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion","volume":"43","author":"O'Gradaigh","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2008.12.002_bib11","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.165.11.6590","article-title":"Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium","volume":"165","author":"Nanki","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2008.12.002_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.20020439","article-title":"Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis","volume":"196","author":"Ji","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2008.12.002_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in the rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2008.12.002_bib14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.23372","article-title":"Reciprocal cross-talk between RANKL and interferon-\u03b3-inducible protein 10 is responsible for bone-erosive experimental arthritis","volume":"58","author":"Kwak","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2005.02850.x","article-title":"Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig\/CXCL9 by synovial fibroblasts","volume":"141","author":"Tsubaki","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2008.12.002_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B","article-title":"Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis","volume":"43","author":"Wedderburn","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.3780248","article-title":"CXCR3 chemokine receptor distribution in normal and inflamed tissues","volume":"81","author":"Garcia-Lopez","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2008.12.002_bib18","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C","article-title":"Selective lymphocyte chemokine receptor expression in the rheumatoid joint","volume":"44","author":"Ruth","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bone.2005.01.021","article-title":"Stromal cell derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts","volume":"36","author":"Wright","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2008.12.002_bib20","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2004-07-2534","article-title":"Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration","volume":"105","author":"Kwak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2008.12.002_bib21","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","article-title":"Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma","volume":"100","author":"Abe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2008.12.002_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/030097498440859","article-title":"Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus","volume":"27","author":"Funauchi","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2008.12.002_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0161-5890(95)00024-9","article-title":"Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-10 and interferon gamma mRNA in the lymph nodes of lupus-prone mice","volume":"32","author":"Prudhomme","year":"1995","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2008.12.002_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.2005.038315","article-title":"Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus","volume":"65","author":"Lit","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2008.12.002_bib25","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2008.12.002_bib26","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signaling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2008.12.002_bib28","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.21745","article-title":"Antagonist of interferon-inducible protein 10\/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL\/lpr mice","volume":"54","author":"Hasegawa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2008.12.002_bib30","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S","article-title":"Overexpression of monocyte chemoattractant protein-1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (\u03b1) and CCL2 (\u03b2) chemokines in systemic sclerosis\u2014a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatol"},{"key":"10.1016\/j.autrev.2008.12.002_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00401-005-0989-5","article-title":"Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies","volume":"109","author":"De Paepe","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2008.12.002_bib33","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/art.21303","article-title":"Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy","volume":"52","author":"Fall","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.12.002_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1196\/annals.1398.050","article-title":"Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses","volume":"1109","author":"De Paepe","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2008.12.002_bib35","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.4049\/jimmunol.175.10.6987","article-title":"Inhibition of CX3CL1 (Fractalkine) improves experimental autoimmune myositis in SJL\/J mice","volume":"175","author":"Suzuki","year":"2005","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:11:42Z","timestamp":1761599502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997208002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1568997208002437"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2008.12.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL10 and autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2008.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}